Jupiter Neurosciences, Inc. · NASDAQ:JUNS
Hayward Marshall A. exercised options for 1,014,195 Jupiter Neurosciences, Inc. shares (Form 4)
Traded Jun 2, 2025 to Mar 2, 2026 · Filed Jul 13, 2026
From Jun 2, 2025 to Mar 2, 2026, Hayward Marshall A. (Director, Chief Scientific Officer) exercised options for 1,014,195 Jupiter Neurosciences, Inc. shares, leaving 2,995,077 shares. Filed Jul 13, 2026 (Form 4).
- Options exercised
- 1,014,195 shares
- Holding after
- 2,995,077 shares
- Trading plan
- No
- Role
- Director, Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 2, 2025 | Common Stock | Option exercise | 389,793 | 2,370,675 | Direct | |
| Jun 2, 2025 | Common Stock | Option exercise | 399,402 | 2,770,077 | Direct | |
| Mar 2, 2026 | Common Stock | Option exercise | 225,000 | 2,995,077 | Direct |
Source
Related
- Jupiter Neurosciences, Inc.
- Hayward Marshall A.
- Jupiter Neurosciences, Inc. shareholders
- Schedule 13G · PharmAla Biotech Holdings Inc. · Sep 22, 2026
- Form 4 · Kampf Julie B. · Jul 13, 2026
- Form 4 · Rosen Alexander Gustaf Erik · Jul 13, 2026
- Form 4 · Hemmerly Nicholas H. · Jul 13, 2026
- Form 4 · Weis Holger · Jul 13, 2026